NASDAQ · HUMA

Humacyte, Inc.

Closing price · Nov 13, 2026 $0.5584

Last insider buy price $0.56 Paid by Director Keith Jones on Sep 14, 2026 (Form 4). Not today's price.

Latest quarter · ended Sep 30, 2026

Cash got weaker, but sales grew

descriptionFiled Nov 10, 2026

Revenue growthFaster

+36.5%

Mar '26Sep '26

$1.03M vs. $753K a year ago

Cash from operationsBetter

−$15M

Dec '24Sep '26

vs. −$23.9M a year ago

Share countDiluting

+48.3%

Dec '24Sep '26

277.8M shares vs. 187.27M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 13 Funds: as of Jun 30, 2026

account_balance
2 funds bought, 0 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
info
No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

162 funds report owning HUMA, up from 156

Holdings as of Jun 30, 2026

New41

Added54

Held33

Trimmed34

Sold out35

Last quarter

Who bought and who sold

Apr–Jun 2026

Antipodes Partners Ltd

+77%

Davidson Kempner Capital Management LP

New

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale

Last 6 months. A wider screen shows 12.

Showing 5 real trades. Hidden: 2 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Sep 14 Keith Jones Director Open-market buy $5.6K 10,000 sh at $0.56

Aug 20 Keith Jones Director Open-market buy $6.9K 10,000 sh at $0.69

Aug 17 Keith Jones Director Open-market buy $17.7K 30,000 sh at $0.59

May 19 Kathleen Sebelius Director Open-market buy $50K 56,818 sh at $0.88

May 18 Michael Constantino Director Open-market buy $9.79K 11,000 sh at $0.89

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in HUMA

As of Jun 30, 2026

Fund	Owns	Value	Change
Antipodes Partners Ltd	3.6%	$7.88M	+77%
Vanguard Capital Management LLC	3.6%	$7.88M	+41%
Alyeska Investment Group, L.P.	2.2%	$4.7M	New
Davidson Kempner Capital Management LP	1.8%	$3.9M	New
BlackRock, Inc.	1.7%	$3.78M	−61%

"Owns" is shares reported divided by shares outstanding.